4/A

FORM 4/A SUBMISSION

Company: Sarepta Therapeutics, Inc.
Filed: March 10, 2021
Period of Report: February 28, 2021
Accession Number: 0001209191-21-019666

View Document ↗ View on SEC.gov ↗